The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients ...
The global automotive labels market is projected to reach a valuation of USD 11,584.7 million by 2033, growing at a compound annual growth rate (CAGR) of 4.3% over the forecast period, according to ...
Hemp retailers in Missouri are trying to work with state lawmakers to place regulations on an industry that still exists unregulated in a legal loophole.
Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 – ...